Agilon Health (AGL) Cash & Current Investments (2020 - 2026)

Agilon Health has reported Cash & Current Investments for 7 years, with the latest figure at $231.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 36.96% year-over-year to $231.4 million; the trailing twelve-month figure through Mar 2026 stood at $231.4 million (down 36.96% YoY), and the FY2025 full-year result was $285.1 million, down 28.71% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $231.4 million, down from $285.1 million in the prior quarter.
• The five-year high for Cash & Current Investments was $1.0 billion in Q1 2022, with the low at $231.4 million in Q1 2026.
• Historically, Cash & Current Investments has averaged $552.7 million across 5 years, with a median of $419.1 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments surged 870.43% — and 2024, when it plunged 48.69%.
• Agilon Health's Cash & Current Investments stood at $877.2 million in 2022, then plunged by 44.33% to $488.3 million in 2023, then slipped by 18.1% to $400.0 million in 2024, then decreased by 28.71% to $285.1 million in 2025, then slipped by 18.84% to $231.4 million in 2026.
• The last three Cash & Current Investments figures came in at $231.4 million (Q1 2026), $285.1 million (Q4 2025), and $310.9 million (Q3 2025), per Business Quant data.